Uremic osteodystrophy. The therapeutic consequences of effective control of serum phosphorus.
D000328:Adult; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D001847:Bone Diseases / Q000175:diagnosis / Q000188:drug therapy*; D002118:Calcium / Q000097:blood; D006225:Hand / Q000000981:diagnostic imaging; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000628:therapy*; D008274:Magnesium / Q000097:blood; D008297:Male; D010002:Osteitis Fibrosa Cystica / Q000175:diagnosis / Q000188:drug therapy; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000097:blood*; D011859:Radiography; D006435:Renal Dialysis / Q000009:adverse effects; D014511:Uremia / Q000175:diagnosis / Q000188:drug therapy*
D010281:Parathyroid Hormone; D010710:Phosphates; D000536:Aluminum Hydroxide; D008274:Magnesium; D002118:Calcium